We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01546376
Recruitment Status : Unknown
Verified January 2009 by Rajavithi Hospital.
Recruitment status was:  Recruiting
First Posted : March 7, 2012
Last Update Posted : March 7, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .

Condition or disease Intervention/treatment
To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT Radiation: Radiation therapy Other: Venepuncture

Study Design

Study Type : Observational
Estimated Enrollment : 100 participants
Time Perspective: Prospective
Official Title: Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
Study Start Date : August 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
HIV-cancer patients who recived RT Radiation: Radiation therapy
External photon beam radiation therapy dosage 4000-7000 CGy
Other: Venepuncture
Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
HIV positive cancer patients Curative RT treatment
Criteria

Inclusion Criteria:

  • Age 18-65 years
  • HIV positive cancer patients
  • Photon beam RT, conventional fraction >= 4000 cgy in 4 weeks

Exclusion Criteria:

  • CD4 count < 200 cell/ml and not received anti retro viral
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01546376


Contacts
Contact: Pathomphorn Siraprapasiri, MD 66-89-6662960 spathomphorm@gmail.com

Locations
Thailand
Rajavithi Hospital Recruiting
Bangkok, Thailand, 10400
Contact: Pathomphorn Siraprapasiri, MD    66-89-6662960    spathomphorn@gmail.com   
Sponsors and Collaborators
Rajavithi Hospital
More Information

Responsible Party: Rajavithi Hospital
ClinicalTrials.gov Identifier: NCT01546376     History of Changes
Other Study ID Numbers: THAIHIV001
First Posted: March 7, 2012    Key Record Dates
Last Update Posted: March 7, 2012
Last Verified: January 2009